• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 MARATHON; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 MARATHON; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number 105-5056
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Respiratory Insufficiency (4462)
Event Date 09/04/2020
Event Type  Injury  
Event Description
Abruzzo, t., abraham, k., karani, k.B., geller, j.I., vadivelu, s., racadio, j.M., zhang, b., <(>&<)> correa, z.M.(2021).Correlation of technical and adjunctive factors with quantitative tumor reduction in children undergoing selective ophthalmic artery infusion chemotherapy for retinoblastoma.Ajnr - american journal of neuroradiology, 42(2), 354¿361.Https://doi.Org/10.3174/ajnr.A6905.Medtronic review of the literature article found that 40 eyes of 35 pediatric patient were treated for retinoblastoma selective ophthalmic artery infusion chemotherapy (soaic).A 1.5f marathon microcatheter was the preferred catheter used in the procedures though it was noted a slightly smaller non-medtronic microcatheter was used in some cases if catheterization with the marathon could not be achieved.However, it was not specified which cases used the non-medtronic catheter.Serious adverse events reported in article included: 2 instances of hypotension in infants receiving intra-arterial verapamil (iav).Both required treatment with blood products.1 patient was also treated with calcium gluconate to counteract verapamil.In 1 case, post extubation laryngospasm required reintubation.Medical safety assessed that this event was not related to the marathon microcatheter but was a procedure-related event.
 
Manufacturer Narrative
Reported patient age (19 months) is representative of the average age from all patients included in the study.Reported patient sex (female) is representative of the majority of patients (12/20) included in the study.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MARATHON
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key15086371
MDR Text Key296411352
Report Number2029214-2022-01220
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K093750
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 07/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number105-5056
Device Catalogue Number105-5056
Device Lot NumberUNKONWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/13/2022
Initial Date FDA Received07/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age19 MO
Patient SexFemale
-
-